TMT1A and choriocarcinoma: Conversely, METTL7A was upregulated in methotrexate-resistant choriocarcinoma cells, the increased METTL7A promoted cell viability, clonogenesis, suppressed apoptosis, and reduced the production of reactive oxygen species, indicating an oncogenic role in choriocarcinoma13.